NCT03250572View on ClinicalTrials.gov

Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among NAFLD Patients

CompletedOBSERVATIONAL
Enrollment

113

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

November 30, 2016

Conditions
Non-Alcoholic Fatty Liver Disease
Interventions
DIAGNOSTIC_TEST

serum ferritin

serum samples and ferritin ELISA test

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT03250572 - Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among NAFLD Patients | Biotech Hunter | Biotech Hunter